Fusion event
HBV-chr22 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TTACTTCCAAACTAGACACTATTTACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGAAACAACACATAGCGCCTCATTTTGTGGGTCACCATAT| |TCTTGGGAACAAGATCTACAGCATGGGGCAGAATCTTTCCACCAGCAATCCTCTGGGATTCTTTCCCGACCACCAGTTGGATCCAGCCTTCAGAGCAAAC
End
21810097/21455808 (Hg38)
Nearest miRNA
hsa-mir-1286/Upstream/421536; hsa-let-7a-3/Downstream/197173;
Upstream sequence
TTGGGAAAGGCAGGCAGGGCTGCAGGCTCCCTAGGAGGCCAGAACTGGCCAGGGGTGCAGCAGCCGAGGCCTCTCCCTGCAGTGCCAGGCTGCGTCCTTT
Downstream sequence
CCCACGCAAAGGCTAGCCTCTGTGCTGTGGAGACCAGACGGGAGGCTGGAGGGCCTTGGTGGCAGTGTAAGAGGCTGGGCCACCAGCAGGGCCCAGGTGT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.